Navigation Links
Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
Date:3/6/2009

Therapure will apply its expertise to the development of an innovative plasma protein resulting from LFB's research

Toronto, Canada and Les Ulis, France (PRWEB) March 6, 2009 -- Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Christian Béchon, President and CEO of LFB S.A. announce that a development services contract has been concluded between Therapure Biopharma Inc. and LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for an innovative plasma therapeutic protein.

Therapure will apply its experience and knowledge in therapeutic protein development to develop a manufacturing process to enable the large scale production of this important biologic for clinical trials. The project, which is being jointly managed by research and development teams from the two companies, is expected to yield a novel treatment for a serious illness which currently has limited treatment options.

"We are pleased that LFB Biotechnologies, a major European player in the therapeutic protein field, has selected Therapure Biopharma for this important work," said Thomas Wellner. "Our development team has extensive knowledge in the area of plasma proteins purification and manufacturing methods and we have already achieved some key milestones in this project."

"We have a strong expertise in the development and manufacture of plasma-derived medicinal products and an important R&D portfolio. We have chosen to identify partners with complementary knowledge and the skills to help us to advance some of our products," said Bernard Pelletier, strategic development program director. "We have recognized the strong technical capabilities of Therapure Biopharma in this area and we are pleased with the progress of the project to date."

About Therapure Biopharma
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma is also a specialist in therapies derived from hemoglobin, a blood protein. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

For more information, please visit: www.therapurebio.com.

About LFB
LFB is a pharmaceutical group and the first French company in the biotech field. LFB is the fifth largest pharmaceutical company in plasma-derived medicinal products in the world, and the third largest laboratory supplying drugs to hospitals in France. LFB commercializes a wide range of 19 plasma-derived medicinal products, addressing more than 80 pathologies in three therapeutic fields: Immunology, Hemostasis, and Intensive Care. Each year, 500,000 patients are treated with LFB's products for chronic pathologies or for emergency cases. In the biotechnology field, LFB develops monoclonal antibodies and a line of therapeutic proteins through transgenic technology with GTC Therapeutics.

For more information, please visit www.lfb.fr.

Media Contact, Therapure Biopharma Inc.:
Alison Withey
+1 705-788-0080

Media Contact, LFB S.A.:
Sandrine Charrières, Corporate Communications Director
+33 169 827 280

# # #

Read the full story at http://www.prweb.com/releases/Therapure_Biopharma/LFB_Biotechnologies/prweb2192744.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
2. Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
3. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
4. China Biopharma, Inc. Issues Corporate Information Update
5. Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
6. Wound Management Technologies, Inc. Announces Negotiations to Acquire BioPharma Management Technologies, Inc.
7. Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying China
8. Keryx Biopharmaceuticals Receives Nasdaq Notification
9. Best Practice Database Provides Key Findings for Biopharma Product Launch Evaluation
10. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
11. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare industry ... for its inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., ... health of America’s healthcare providers. , The conference was highlighted by the announcement ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... has a significant negative impact on long-term patient survival, reports a team of ... published online this week in the Journal of Thoracic and Cardiovascular Surgery, provide ...
(Date:5/26/2016)... ... , ... An April Gallup survey found rising health care costs to be ... Health Senior Living (SHSL) may not share those same worries thanks to a ... the year, while holding the line on increasing their contributions, including premiums, deductibles and ...
(Date:5/26/2016)... Fla. (PRWEB) , ... May 26, 2016 , ... The ... (AHEC) to host a six-week smoking cessation class starting June 6 at their clinic ... website, http://www.gnahec.org . , Additionally, the Lung Institute has created a free downloadable ...
(Date:5/26/2016)... Scotch Plains, NJ (PRWEB) , ... May 26, ... ... year being recognized as an NJ Top Doc! Along with his wonderful accolades ... to excellence in podiatry. Congratulations, Dr. Batelli! , Dr. Eugene Batelli is ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 Dutch surgeons have launched a ... the world and treat patients on a global scale. Medical professionals ... Asia and the US have already signed ... and networking in a totally secure environment. Education  ... zone working together with a surgeon at Harvard to treat a ...
(Date:5/23/2016)... 2016 According to a ... by Product (Wheelchair, Scooters, Medical Beds, Bathroom Safety, ... Care, Wound), Accessories (Lifting, Transfer) & by End ... by MarketsandMarkets, the patient handling equipment market is ... at a CAGR of 10.5% during the forecast ...
(Date:5/23/2016)... May 23, 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) ... and Internship programs. The hands-on learning experience is a ... full-time, paid Fellowship and Internship ... . Fellows and interns are provided optional housing free ... at the Riverfront Residence Hall to foster ...
Breaking Medicine Technology: